StonvexLoading…
StonvexStonvexStonvexCore line items from NGG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | £18.38B | £19.85B | £21.66B | £18.45B |
Operating Income | £4.93B | £4.47B | £4.88B | £4.37B |
Net Income | £2.90B | £2.29B | £7.80B | £2.35B |
EPS (Diluted) | £0.61 | £0.57 | £1.96 | £0.65 |
Total Assets | £106.74B | £98.33B | £92.70B | £94.86B |
Total Liabilities | £68.92B | £68.43B | £63.13B | £71.00B |
Cash & Equivalents | £1.18B | £559.00M | £163.00M | £204.00M |
Free Cash Flow OCF − CapEx | £-1.97B | £35.00M | £18.00M | £392.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |